Publications by authors named "Kai Nishimura"

Claim this Profile
A
Alanine-serine-cysteine transporter-targeted small-molecule boron carriers for neutron capture therapy of L-4‑boronophenylalanine-refractory tumors.
Kazuki Miura, Tomoyuki Araki, Taiki Morita, Kai Nishimura, Satoshi Okada

J Control Release· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Carrier-Free Metallacarboranes for Targeted Radiation Therapies PBFT and BNCT: Comparative Cellular Effects and Dosimetry Studies with [-FESAN] in Breast Cancer Cells.
Salvatore Di Maria, Teresa Pinheiro, Luís Cerqueira Alves, Valeria Bitonto, Nicoletta Protti, Kai Nishimura

Pharmaceuticals (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of reactor vs. accelerator-based boron neutron capture therapy in U87MG glioblastoma models.
Kai Nishimura, Kazuki Miura, Hiroki Tanaka, Minoru Suzuki, Hiroyuki Nakamura

Appl Radiat Isot· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boron neutron capture therapy with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP) for a head and neck squamous cell carcinoma (SAS) model mice.
Kazuki Miura, Kai Nishimura, Minoru Suzuki, Hiroyuki Nakamura

Appl Radiat Isot· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BODIPY-Based Photothermal Agent Incorporating Azulene for Enhanced NIR Absorption and Tumor Ablation.
Kai Nishimura, Mikiya Kato, Tomoya Fukui, Kazuki Miura, Masato Tsuda

Mol Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]) in breast cancer cells.
Ana Belchior, Bianca C Alves, Edgar Mendes, Francisco Megre, Luís C Alves, Kai Nishimura

EJNMMI Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture Therapy.
Kai Nishimura, Shota Tanaka, Kazuki Miura, Satoshi Okada, Minoru Suzuki

ACS Omega· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier.
Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Yoshiki Fujikawa, Ryo Kayama

Neurooncol Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Satoshi Okada, Kai Nishimura, Qarri Ainaya, Kouichi Shiraishi, Sergey A Anufriev

Mol Pharm· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated -Dodecaborate on a Rat Brain Tumor Model.
Yoshiki Fujikawa, Yusuke Fukuo, Kai Nishimura, Kohei Tsujino, Hideki Kashiwagi

Biology (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP).
Kai Nishimura, Hideki Kashiwagi, Taiki Morita, Yusuke Fukuo, Satoshi Okada

J Control Release· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model.
Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Ryo Kayama, Kohei Yoshimura

Biology (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor.
Kai Nishimura, Suzanna Harrison, Kazuki Kawai, Taiki Morita, Kazuki Miura

Bioorg Med Chem Lett· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Hideki Kashiwagi, Shinji Kawabata, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Kai Nishimura

Invest New Drugs· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic RGD-Functionalized -Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy.
Kazuki Kawai, Kai Nishimura, Satoshi Okada, Shinichi Sato, Minoru Suzuki

Mol Pharm· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis